07 June 2019 Written by CN1699 Services Article viewed 41 times (2 times in the last week)

ReStore Exo-Suit, by Rewalk Robotics, a company in Marlborough, Massachusetts and Yokneam Ilit, Israel, won FDA approval and a CE mark. The ReStore Exo-Suit had its beginnings at Harvard’s Wyss Institute for Biologically Inspired Engineering, made of a soft wrap that is placed around a lower leg that is affected by a stroke, a backpack-like control center, and a matching app that lets rehab specialists adjust its settings.

 “The exo-suit achieves our commercial goal to offer a functional and affordable system that can be utilized in the ‘Main Street’ clinics in every community, with a launch price of $28,900 as well as leasing options, ReStore offers cutting edge innovation with features that redefine therapy at a price that is accessible for a broader range of clinics than existing robotic technologies. The current gait training reimbursement codes enable immediate penetration and sales growth as part of our pathway to become a break even and profitable company, "said ReWalk CEO Larry Jasinski, in a published statement.

Additionally to being a walking aid during therapy, the suit gathers a great deal of data during each patient session to help rehab specialists to assess their patients and to alter the kind of therapies that are delivered to attain the best results.

For more information, visit:

ReWalk

Photo by: ReWalk


Read more related topics:

Rehabilitation | WalkingAid

Grace T

Managing Editor - CN1699 Services